HeartFlow Analysis
Overview
HeartFlow Analysis is an AI-powered medical device software that transforms standard coronary computed tomography angiography (CCTA) images into a personalized, digital 3D model of a patient’s coronary arteries. This non-invasive diagnostic tool leverages advanced artificial intelligence and computational fluid dynamics (CFD) to simulate blood flow and assess the impact of blockages on coronary blood flow. The platform provides clinicians with detailed insights, including fractional flow reserve (FFRct) values, plaque localization and characterization, and anatomical data, to aid in the diagnosis, risk assessment, and treatment planning for coronary artery disease (CAD). It aims to improve diagnostic accuracy, reduce the need for unnecessary invasive procedures, and enable personalized care pathways for patients with suspected or known CAD.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered 3D modeling of coronary arteries
- Fractional Flow Reserve derived from CT (FFRct) analysis
- Plaque Analysis (quantification and characterization)
- Roadmapu2122 Analysis for CCTA reading
- Non-invasive diagnostic assessment
- Personalized patient insights
- Computational Fluid Dynamics (CFD) for blood flow simulation
- High diagnostic accuracy
- Reduces need for unnecessary invasive procedures
- Supported by extensive clinical evidence and guidelines
Use Cases
- Diagnosing coronary artery disease (CAD)
- Assessing the functional significance of coronary stenoses
- Guiding treatment decisions (medical therapy, revascularization)
- Risk stratification for major adverse cardiovascular events (MACE)
- Reducing unnecessary invasive diagnostic coronary angiograms
- Optimizing care pathways for patients with stable or acute chest pain
What Physicians Need to Know
HeartFlow Analysis is a non-invasive tool that uses CCTA scans to provide a personalized 3D model of coronary arteries, assessing plaque and blood flow (FFRCT). This can help determine if a blockage is causing ischemia, potentially avoiding unnecessary invasive procedures like catheterization. The detailed insights into plaque characteristics and blood flow can guide treatment decisions, from lifestyle changes to revascularization. It is particularly useful for patients with suspected Coronary Artery Disease (CAD) where more clarity is needed after a standard CT scan. The HeartFlow Analysis is intended to be used in conjunction with the patient's clinical history, symptoms, and other diagnostic data, as well as the clinician's professional judgment.
HeartFlow Analysis integrates into the clinical workflow by processing CCTA images. The analysis results, including personalized models and plaque volumes, are delivered in a downloadable PDF report and can be integrated into PACS and EMR systems. The CCTA images are securely uploaded from the hospital's system to HeartFlow's software application.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing | Contact vendor for pricing |
| Deployment | Cloud-based (AWS) |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Yes AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Radiology |
What the Web Says
HeartFlow Analysis is a non-invasive diagnostic tool for coronary artery disease (CAD) that uses CT scan data, 3D modeling, and artificial intelligence to assess blood flow and the impact of blockages. It aims to provide a more comprehensive understanding of a patient's coronary disease burden, helping physicians determine the optimal course of treatment and potentially reduce the need for invasive procedures. The technology has received positive reviews from medical professionals and has been adopted by numerous hospitals, particularly in the UK's NHS.
Overall: PositiveStrengths
- Non-invasive and safe, providing both anatomical and functional data.
- High diagnostic accuracy, especially in identifying obstructive coronary disease and improving specificity compared to CCTA alone.
- Can reduce the need for unnecessary invasive coronary angiography (ICA) and associated risks.
- Helps physicians differentiate patients who need invasive procedures from those who can be managed with medication.
- Provides a more comprehensive understanding of coronary disease, including plaque analysis and characterization.
- Potential for cost savings in healthcare by avoiding costly, unnecessary procedures.
Limitations
- Some CTCA datasets may be unsuitable for analysis due to technical issues like motion artifact or extensive calcification.
- The cost of HeartFlow Analysis can be significant and may exceed that of performing a second in-house stress-based test.
- Not all imaging centers that perform CCTA provide HeartFlow analysis.
- Some Reddit discussions suggest that adoption might be limited in certain medical communities.
- Employee reviews on platforms like Comparably and Indeed indicate mixed opinions on compensation and management, with some reporting low pay for the region.
- Limited public reviews available on platforms like G2 and Capterra directly from users of the HeartFlow Analysis product.
Based on reviews from: heartflow.com, bjcardio.co.uk, nih.gov, auntminnie.com, medicaldevice-network.com, cardiovascularbusiness.com, elion.health, greatplacetowork.com, comparably.com, indeed.com, dicardiology.com, fda.gov, g2.com, sgno.org, ihirehealthcareadministration.com, scot.nhs.uk, medaiverdict.com, stocktitan.net, reddit.com, sourceforge.net, expertini.com, softwareadvice.com, capterra.com, cardiovascularnews.com
Last updated: 2026-10-30
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate HeartFlow Analysis
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for HeartFlow Analysis.
Heartflow's Story
Frequently Asked Questions
Compare HeartFlow Analysis
VS
VS
VS
VS
Investors who backed HeartFlow Analysis
Funded through the company that built this tool.
